New hope for Drug-Resistant lung cancer: experimental pill enters human trials
NCT ID NCT06567015
First seen Oct 31, 2025 · Last updated Jun 15, 2026 · Updated 34 times
Summary
This study tests a new oral drug, STX-241, in people with advanced non-small cell lung cancer that has become resistant to standard targeted therapies. The drug is designed to reach the brain and attack cancer cells with specific genetic changes. The trial aims to find the safest and most effective dose while monitoring side effects and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Hôpital de la Timone
RECRUITINGMarseille, 13385, France
Contact
-
Centre Léon Bérard
RECRUITINGLyon, 69008, France
Contact
-
Centro Intergral Oncologico Clara Campal (CIOCC) (START Madrid)
RECRUITINGMadrid, 28050, Spain
Contact
-
Gustave Roussy
RECRUITINGVillejuif, 94800, France
Contact
-
Hospital Universitario La Paz
RECRUITINGMadrid, 28046, Spain
Contact
-
Institut Universitaire du Cancer de Toulouse - Oncopole
RECRUITINGToulouse, 31059, France
Contact
-
Institut de Cancérologie de l'Ouest (ICO) - René Gauducheau
RECRUITINGSaint-Herblain, 44800, France
Contact
-
National Taiwan University Hospital
RECRUITINGTaipei, 10002, Taiwan
Contact
-
Netherlands Cancer Institute
RECRUITINGAmsterdam, 1066 CX, Netherlands
Contact
-
Oncology Consultants (OC) - Texas Medical Center - Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Sarah Cannon Research Institute (SCRI) (The SCRI Oncology Research Consortium)
RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
Shanghai East Hospital, Tongji University
RECRUITINGShanghai, 200120, China
Contact
-
Taipei Veterans General Hospital
RECRUITINGTaipei, 11217, Taiwan
Contact
-
Tianjin Medical University Cancer Institute and Hospital
RECRUITINGTianjin, 300060, China
Contact
-
Universitätsklinikum Carl Gustav Carus Dresden
RECRUITINGDresden, 1307, Germany
Contact
-
Vall d'Hebron Institut d'Oncologia
RECRUITINGBarcelona, 8035, Spain
Contact
Conditions
Explore the condition pages connected to this study.